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The amyloidogenicity of gelsolin is controlled by proteolysis 
and pH 
Gayathri Ratnaswamy l, Edward Koepfl, Haimanot Bekelel, Helen Yin* 
and Jeffery W Kelly’ 
Background: Normally, gelsolin functions in plasma as part of the actin- 
scavenging system to assemble and disassemble actin filaments. The 
Asp1 87-+Asn (D187N) and Asp1 87+Tyr (D187Y) gelsolin mutations facilitate 
two proteolytic cuts in the parent protein generating a 71 -residue fragment that 
forms amyloid fibrils in humans, putatively causing Finnish type familial 
amyloidosis (FAF). We investigated the role of the D187N mutation in 
amyloidogenicity using biophysical studies in vitro. 
Results: Both the recombinant wild-type and D187N FAF-associated gelsolin 
fragments adopt an ensemble of largely unfolded structures that do not self- 
associate into amyloid at pH 7.5. Incubation of either fragment at low pHs 
(6.0-4.0) leads to the formation of well-defined fibrils within 72 hours, however. 
Conclusions: The D187N mutation has been suggested to destabilize the 
structure of the gelsolin parent protein (specifically domain 2), facilitating two 
proteolytic cleavage events. Our studies demonstrate that generating the 
largely unstructured peptide is not sufficient alone for amyloid formation in vitro 
(on a time scale of months). A drop in pH or an analogous environmental 
change appears necessary to convert the unstructured fragment into amyloid 
fibrils, probably through an associative mechanism. The wild-type gelsolin 
fragment will make amyloid fibrils from pH 6 to 4 in vitro, but neither the wild- 
type fragment nor fibrils have been observed in v&o. It is possible that domain 2 
of wild-type gelsolin is stable in the context of the whole protein and not 
susceptible to the proteolytic degradation that affords the 71 -residue 
FAF-associated peptide. 
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Introduction 
Human gelsolin is expressed both as an 81 kDa intracellu- 
lar protein and as a secreted 84 kDa extracellular polypep- 
tide [1,2], each composed of six domains. Gelsolin 
functions in at least three ways: it binds two actin 
monomers to nucleate actin polymerization; it can bind to 
tilamentous actin and sever the noncovalent bonds of the 
polymer; and it caps the rapidly polymerizing end of 
F-actin following severing. These functions are activated 
by micromolar CaZ+ concentrations and possibly by pHs < 6 
[3]. Extracellular gelsolin is thought to be an important 
component of the actin-scavenging system that removes 
actin released from dead cells into the bloodstream [4]. An 
Asp187-+Asn (D187N) or Asp187-+Tyr (D187Y) mutation 
in domain 2 of the 84 kDa secreted form of gelsolin allows 
a single proteolytic event between Argl72 and Ala173 
during secretion [5]. Upon arrival in the plasma, a sec- 
ondary proteolytic event occurs, which results in a 
71-residue gelsolin fragment (residues 173-243) that is 
sometimes found deposited in the cranial or peripheral 
nerves, the cornea and in a variety of other tissues in indi- 
viduals with Finnish type familial amyloidosis (FAF) [S]. 
These deposits have the morphology and dye-binding 
properties characteristic of amyloid fibrils associated with a 
variety of neurodegenerative diseases [6-91. 
Significant insight into the structure-function relationships 
of human gelsolin was revealed when the crystal structure 
of highly homologous horse plasma gelsolin was solved [lo]. 
In terms of the structure of domain 2, proteolytic processing 
of domain 2 position 187 variants results in the removal of 
strands 1 and 3 (shown in gray in Figure l), which probably 
alters the structure of the 71-residue 173-243 gelsolin 
FAF-associated fragment, owing to the deletion of one inte- 
gral and one exterior p strand [lO,ll]. The crystal structure 
demonstrates that the position of the FAF-associated muta- 
tions (at residue 187) are proximal to the disulfide bond 
between the Cys188 and Cys201 residues linking strands 4 
and 5, probably destabilizing the extracellular form of gel- 
solin directly by interfering with disulfide-bond formation 
or by interfering with the hydrogen bonding between the 
Asp187 sidechain and its partners (Asn184, Lys166 and 
Gln164; Figure l), or both [lO,ll]. The apparent impor- 
tance of the Asp187 sidechain for protein structure and/or 
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Figure 1 
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Ribbon diagram representation of the polypeptide backbone of the 
horse plasma gelsolin S2 domain. The other five domains have been 
omitted for clarity. The amyloidogenic fragment (173-243) is cyan, 
whereas the remainder of the S2 domain is gray. The sidechain of the 
FAF-associated mutation (Asp1 87) is illustrated along with the 
sidechains of Glnl64, Lys166 and Asnl84, residues that are within 
hydrogen bonding distance of Asp1 87. The disulfide bond between 
Cys188 and CysPOl and the location of the tryptophan residues (W) 
are also indicated. This figure was prepared using MOLSCRIPT [731. 
function is reflected in the fact that this residue is highly 
conserved in the gelsolin family of proteins. 
Studies with nine- and ll-residue peptides from gelsolin 
(residues 183-191 and 182-192, respectively) reveal that 
these small peptides that incorporate the FAF-associated 
mutation D187N or D187Y form amyloid-like fibrils, 
whereas the wild-type nonapeptide might not (the unde- 
capeptide is weakly amyloidogenic via a Congo red assay 
but not by a thioflavine T-based fluorometric evaluation) 
[12]. These results imply that the mutations themselves 
directly control amyloid formation [12]. Peptide frag- 
ments of amyloidogenic proteins can give misleading 
results, however, as some peptides not associated with 
amyloid sequences can form amyloid-like fibrils in vitro 
[13,14] (H. Lashuel and J.W.K., unpublished observa- 
tions). Here, we evaluate the amyloidogenicity and con- 
formational stability of both the wild-type and D187N 
FAF-associated gelsolin fragments. The fragments 
studied have a Gly-Ser- (GS-) sequence attached to the 
amino terminus of the 71-residue amyloidogenic frag- 
ment as a result of the recombinant expression system 
employed. Somewhat surprisingly, the wild-type gelsolin 
fragment GS-173-243 is amyloidogenic (the opposite to 
what was observed by analysis of short peptides), albeit 
slightly less so than the D187N GS-173-243 gelsolin 
variant [12]. Interestingly, both the wild-type and D187N 
GS-173-243 gelsolin variants form amyloid fibrils within 
72 h after encountering slightly acidic conditions in vitro 
- that is, proteolysis of the parent gelsolin protein does 
not appear to be sufficient for amyloid fibril formation 
within a 3 month observation period at pHs higher 
than 6.0, 37°C. Low pH conditions probably lead to pro- 
tonation of key carboxylate and imidazole sidechains, in 
addition to probably altering the distribution of largely 
unordered conformational states, allowing assembly- 
mediated conformational changes and ultimately amyloid 
fibril formation to occur on a time scale that allows bio- 
physical studies to be performed. It might be that condi- 
tions other than a low pH environment convert gelsolin 
very slowly into amyloid fibrils in viva (on a time scale of 
years); we have yet to identify these conditions, however. 
The results of this study suggest that the predominant 
effect of the mutations is to enable proteolysis of the 
parent protein. 
Results 
Expression, purification and characterization of wild-type 
and D187N GS-173-243 fragments of gelsolin 
The gelsolin 173-243 fragment was expressed as an 
amino-terminal His-tagged glutathione S-transferase 
(GST) fusion protein incorporating a thrombin cleavage 
site between (His),GST and the gelsolin 173-243 
polypeptide [15]. Purification of the soluble fusion 
protein was achieved by passing the total cell lysate 
through glutathione sepharose affinity resin, eluting the 
fusion protein with 10 mM reduced glutathione at pH 8. 
Bovine thrombin was added directly to the fusion protein 
in the glutathione elution buffer to liberate the 71-residue 
gelsolin peptide. The wild-type and D187N gelsolin frag- 
ments contain two extra amino acids at their amino-termi- 
nal ends (GS-), an artefact of the recombinant expression 
system used to create the peptides. The GST protein was 
removed from the GS-173-243 gelsolin peptide by 
passing the reaction mixture through a Ni-NTA column. 
The Ni-NTA elutant containing gelsolin GS-173-243 
was concentrated by ultrafiltration and purified to homo- 
geneity using gel filtration chromatography. Electrospray 
ionization mass spectrometry (ESI-MS) confirmed that 
the masses of the wild-type GS-173-243 fragment 
(8136.8 amu) and the D187N GS-173-243 fragment 
(8135.6 amu) are correct. The mass spectrometric mea- 
surements were consistent with oxidized gelsolin GS 
173-243 - that is, gelsolin having an intramolecular 
disulfide bond. This interpretation was confirmed by 
preparing disulfide oxidized and reduced forms of both 
wild-type and D187N GS-173-243 gelsolin. Reverse- 
phase high performance liquid chromatography (HPLC) 
analysis demonstrated that the recombinant GS-173-243 
gelsolin used in these studies co-elutes with the oxidized 
standard of gelsolin GS-173-243, Figure 2. To evaluate 
the suitability of gelsolin for amyloidogenicity and bio- 
physical studies, sedimentation equilibrium analytical 
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Reverse phase HPLC analysis of wild-type GS-173-243 gelsolin to exhibits a retention time of 22.1 min (oxidized). (b) HPLC 
probe the oxidation state of Cysl88 and CysPOl. (a) HPLC chromatogram of co-injected oxidized and reduced gelsolin exhibiting 
chromatogram of freshly purified recombinant wild-type gelsolin, which retention times of 22.1 and 25.4 min, respectively. 
ultracentrifugation studies were performed on gelsolin to 
evaluate its quaternary struct:ure, or lack thereof, in 
aqueous solution. The gelsolin concentration distribution 
as a function of radial distance along the cell fits to an 
ideal species model having a solution molecular weight of 
8135 f  148 Da, demonstrating the monomeric nature of 
wild-type and D187N gelsolin (125 PM) at pH 7.4 (see the 
Supplementary material section). Gelsolin GS-173-243 
does not readily aggregate as a 25 l.tM solution at pH 7.4, 
making it feasible to study its conformational properties at 
neutral pH and amyloidogeniciry under acidic conditions. 
Evaluating the amyloidogenicity of wild-type and D187N 
GS-173-243 gelsolin 
The amyloidogenicity of purified gelsolin (GS-173-243) at 
either 0.2 mgjml (25 PM) or 0.02 mg/ml (2.5 @I) was eval- 
uated as a function of pH using 0.5 pH unit steps over the 
range of 4.0-7.5 (100 mM NaCP). The samples were incu- 
bated at 4°C or 37°C for several days to several months and 
evaluated using light scattering and Congo red binding 
analysis (a dye that shows selectivity for amyloid fibrils) 
[16]. Samples that appeared not to exhibit amyloid fibril 
formation by the methods mentioned above were evalu- 
ated further using electron microscopy (EM) to probe 
whether the absence of Iibrils was due to the inability to 
detect them by optical methods. Neither the wild-type 73- 
residue gelsolin peptide nor the FAF-associated D187N 
variant peptide form amyloid fibrils over the pH range of 
7.5-6.0 after incubation for 72 h at 37°C. We have been 
unable to detect amyloid fibrils in 25 FM wild-type and 
D187N GS-173-243 gelsolin samples incubated at pH 7.5 
for more than a month by light scattering and electron 
microscopy analysis. Interestingly, both the wild-type and, 
to a greater extent, the D187N FAF-associated 
GS-173-243 gelsolin fragments (‘25 @I) readily form 
amyloid fibrils over the pH range of 6.0 to 4.0 within 72 h 
(Figure 3). Gelsolin fibril formation is concentration depen- 
dent; no fibril formation was observed for either the wild- 
type or D187N gelsolin 73-residue fragments incubated at 
a concentration of 2.5 @l over 2 months (pH 7.5-4.0). An 
EM study of a 25 @I sample of wild-type (Figure 4a) and 
D187N (Figure 4b) GS-173-243 gelsolin incubated at 
pH 4 forms well-defined amyloid fibrils as visualized 
employing 1% uranyl acetate as a negative contrast agent. 
The Fourier-transform infrared (FT-IR) spectra of wild- 
type (Figure 5a) and D187N (Figure 5b) GS-173-243 gel- 
solin tibrils are virtually identical and exhibit the amide I 
stretch (amide C=O stretch) at 1623 cm-’ and a high fre- 
quency band at 1692 cm-’ characteristic of p-sheet struc- 
ture in the amyloid core (Figure 5) [6,17]. The wild-type 
GS-173-243 amyloid fibrils do not exhibit the classical red- 
shifted Congo red spectrum exhibited by the D187N 
GS-173-243 gelsolin amyloid fibrils, however, suggesting 
that there might be subtle differences between wild-type 
and variant librils. Temperature also appears to be very 
important for gelsolin amyloid fibril formation. The mutant 
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Evaluating gelsolin amyloidogenicity as a function of pH. (a) Light 
scattering (black bars) and Congo red (CR) binding (gray bars) 
analyses of wild-type GS-173-243 gelsolin amyloid fibril formation as 
a function of pH. The Inset displays the vrsrble spectra for the addition 
of 550 1.11 of a 10 PM Congo Red solutron to a 100 fl suspensron of 
wild-type (solid line) and D187N (dashed line) GS-173-243 gelsolin 
fibrils prepared as described in the Materials and methods sectron 
(gelsolin fibril formation assays). This comparison demonstrates the lack 
of a red shift in the binding of Congo red to wild-type gelsolin fibrils. (b) 
Bar graph representing an analogous study evaluating the 
amyloidogenrcity of the D187N gelsalin variant. Gelsolin 
amylordogencccty was studied emptoytng 25 uM GS-I 73-243 samples 
(50 mM buffer, 100 mM NaCI) after Incubation at 37% for 72 h. 
GS-173-243 fragment will only inefficiently form amyloid 
fibrils at 4°C - that is, only after 2 months of incubation 
(2SpM D187N gelsolin GS-173-243 at pH4). The salt 
dependence associated with gelsolin (GS-173-243) fibril 
formation is also very interesting; 100 mM NaCl enables 
fibril formation, whereas 25 mM NaCl does not allow fibril 
formation to occur at otherwise optimal conditions. The 
rate of gelsolin fibril formation is much faster if the sample 
is inverted once every hour, implying that shearing of 
growing amyioid fibrils accelerates rheir growth, which 
might be attributed to seeding. Ongoing mechanistic 
experiments are needed to understand the rate acceleration 
associated with agitation. 
Conformational analysis of the wild-type and D187N 
GS-173-243 gelsolin monomers 
The key questions going into this study regarding the con- 
formation of the gelsolin amyloidogenic fragment were, 
firstly, is there residual structure in the 173-243 fragment? 
and, secondly, are there pH or other environment-depen- 
dent conformational changes that explain the amyloido- 
genicity of wild-type and D187N gelsolin discussed 
above? The structure of the 73-residue gelsolin amyloid 
fragment was probed using a number of spectroscopic 
methods including far-UV circular dichroism (CD), 
lH nuclear magnetic resonance (NMR) including H/D 
exchange studies, tryptophan-fluorescence anisotropy 
measurements, and ANS-fluorescence-based binding 
studies, Neither the wild-type nor the D187N variant of 
gelsolin (35-173-243 exists as a structured polypeptide in 
solution under the conditions evaluated in this study. Both 
wild-type and D187N gelsolin GS-173-243 appear to 
adopt a family of largely unordered structures, in which 
the ensemble of states is only partially constrained by a 
disulfide bond and possibly other weak interactions. 
In the structured environment of a folded protein, the 
rotational mobility of tryptophan residues is restricted. 
Tryptophan residues in a rigid environment exhibit a 
maximal anisotropy value of -0.17 (excitation at 280 nm) 
[18I. The measured single-paint tryptophan-fluorescence 
anisotropy values of -0.06 derived from the Trpl80 and 
Trp200 residues in both rhe wild-type and the D187N 
variant are pH independent (Figure 6) suggesting that 
there are no defined conformational changes detected in 
the local environment of the tryptophan residues that are 
mediated by changes in pH. The far-UV CD data that 
characterizes both the wild-type and DS87N FAF-associ- 
ated variant GS-173-243 gelsolin are consistent with a 
lack of regular secondary structure (there is an intense 
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Figure 4 
Transmission electron microscopy characterization of gelsolin fibrils. 
(a) Electron micrograph of wild-type gelsolin fibrils obtained by 
incubating the gelsolin peptide fragment at pH 4.0, 37°C (in 50 mM 
acetate, 100 mM NaCI). The average diameter of the wild-type fibrils is 
180 f 10 A. Scale bar, 1 pm. (b) Electron micrograph of the D187N 
gelsolin fragment obtained using the same conditions for the wild-type 
sample. The average diameter of the Cl 87N fibrils is 230 f 10 A. 
Scale bar, 2 urn. The insets in both the figures are magnified views of a 
single fibril. 
minimum centered around 197 nm at both pH 7 and pH 4 
after less than 1 h incubation at 4°C; Figure 7). These 
data demonstrate that the unaggregated unordered struc- 
ture formed at pH 4 under conditions ultimately capable 
of fibril formation is not distinguishable from the struc- 
ture formed at pH 7; there are, therefore, no easily dis- 
cernible pH-mediated conformational changes. The lack 
of dispersion in the upfield methyl region (no peaks 
upfield of 0.7 ppm), as well as in the downfield amide 
region (no peaks downfield of 8.6 ppm) of the ‘H NMR 
spectrum confirms the absence of well-defined secondary 
and tertiary structure (Figure 8). Dissolution of 
lyophilized gelsolin into deuterated buffer at pH 7.4 (not 
corrected for the D isotope effect) shows complete 
exchange of the gelsolin amide protons after 5 min, the 
dead time of the NMR manual mixing experiment 
(folded proteins exhibit protection against H/D exchange 
for most residues participating in intramolecular hydro- 
gen bonding). Furthermore, the chemical shifts of the 
indole NH protons (Trpl80 and Trp200) overlap at a 
chemical shift of 10.18 ppm, a value expected for a tryp- 
tophan residue in a random coil [19]. Lastly, the inability 
of GS-173-243 gelsolin to bind ANS at pH 7.4 and 4.4 
relative to the significant binding characterizing the gel- 
solin A-state formed at pH 2 is consistent with a largely 
unordered structure lacking organized hydrophobic 
patches (Figure 9) [ZO-231. 
Discussion 
The results outlined above document that both the wild- 
type and D187N FAF-associated variant gelsolin frag- 
ments GS-173-243 can form amyloid librils in vitro over 
the pH range of 6.04.0 on a time scale commensurate with 
biophysical measurements. Interestingly, only D187N gel- 
solin is proteolytically cleaved into the 71-residue amy- 
loidogenic fragment and transformed into amyloid fibrils in 
viva [24-B]. Neither proteolysis nor Gbril formation has 
ever been observed for wild-type gelsolin in humans. The 
probable reason for this is that the wild-type gelsolin 
protein (organized into six folded domains) does not get 
cleaved to make the 173-243 fragment, owing to its 
increased stability or folding rate relative to the D187N 
gelsolin protein [5,11,29-341. The D187N mutation might 
destabilize this portion of the gelsolin protein or slow down 
its rate of folding making it susceptible to proteolysis. It 
seems likely that proteolysis would facilitate rapid unfold- 
ing of the liberated 173-243 fragment. The timing, degree 
of and rate of unfolding relative to the two proteolytic 
events is currently unknown, however, and is the subject 
of ongoing studies in our laboratory. 
An important finding of this study is that proteolysis 
appears to be necessary, but not sufficient, for gelsolin 
amyloid fibril formation (GS-173-243). The simulation 
of physiological conditions (pH 7.5, 37°C 100 mM NaCl) 
does not appear to be sufficient to convert either the 
wild-type or the D187N gelsolin amyloidogenic fragment 
into amyloid fibrils on a time scale allowing biophysical 
experiments (< 3 months). Dropping the pH below 6.0 
facilitates amyloid fibril formation, however, allowing us 
to study the mechanism of gelsolin amyloidosis on a time 
scale of days. The pH dependence of gelsolin 
GS-173-243 fibril formation is interesting because a 
number of amyloid proteins, including AD, amylin, gel- 
solin and transthyretin form amyloid fibrils optimally 
under acidic conditions around pH 5 [35-43]. These 
observations suggest that amyloid fibril formation could 
occur in an acidic organelle such as an endosome or lyso- 
some, or via the intermediacy of the acidic extracellular 
matrix, something we are investigating further employing 
cell biology approaches [4449]. At the present time, 
however, we have no evidence for endosomal or lyso- 
somal involvement in amyloid fibril formation in humans. 
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Infrared analysis of the secondary structure of gelsolin amyloid. 
(a) FT-IR spectra of fibrils formed from the wild-type gelsolin fragment. 
(b) FT-IR spectra of fibrils formed by the D187N variant. The solid 
lines represent the observed data and the dotted lines are the second 
derivative spectra. The amide I stretches are identified by arrows. 
It is important to realize that environmental changes 
other than pH changes could also facilitate gelsolin fibril 
formation in v&o. 
The D187N or D187Y mutation neutralizes the charge at 
position 187, which by itself is not sufficient to make the 
Figure 6 
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Tryptophan-fluorescence anisotropy measurements as a function of pH 
for the wild-type (+) and the D187N (0) GS-173-243 gelsolin 
peptides. The measurements were made on 1 PM gelsolin samples at 
20°C. Each point on the graph represents an average of 25 
measurements. 
gelsolin GS-173-243 amyloidogenic (see the pH 7.5 data, 
Figure 3) on an experimental timescale. Changing the 
charge state on gelsolin by lowering the pH (protonating 
the carboxylate and imidazole sidechains) probably influ- 
ences the ensemble of unordered conformations and prob- 
ably favors aggregation, which appears to drive the P-sheet 
structural transition and the higher-order assembly 
thought to be important for amyloid fibril formation 
[50,51]. Lowering the pH does not appear to facilitate a 
detectable unstructured to structured transition in the 
monomer (Figure 7); it is reasonable, therefore, to propose 
that self-assembly mediates the observed structural 
changes observed in the fibril (Figure 5). The salt depen- 
dence associated with gelsolin (GS-173-243) fibril forma- 
tion is also very interesting and probably manifests itself 
in the assembly reaction by screening unfavorable 
charge-charge interactions. It is not yet clear whether gel- 
solin amyloid fibril formation is susceptible to seeding 
[SZ]. Interestingly, the rate of gelsolin amyloid fibril for- 
mation is markedly increased by inverting the unseeded 
gelsolin solution once every hour. Further experiments are 
necessary to understand these interesting results. 
Understanding the mechanism by which a soluble protein is 
transformed into a largely insoluble b-sheet rich quaternary 
structure, referred to as an amyloid fibril, is critical for 
further understanding the role that these fibrils or their pre- 
cursors play in human disease [9,53,54]. The amyloid 
hypothesis invokes the process of amyloid fibril formation as 
the causative agent in human amyloid disease, a hypothesis 
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Far-UV CD evaluation of gelsolin GS-173-243 secondary structure pH 7.0 (0; 50 mM sodium phosphate), both with100 mM NaCl at 4°C. 
as a function of pH. (a) Spectra of a 25 PM solution of wild-type (b) Spectra of D187N GS-173-243 gelsolin at pH 4.0 (0) and at 
gelsolin GS-173-243 at pH 4.0 (0; 50 mM sodium acetate) and at pH 7.0 (0) under the same conditions as used in (a). 
that has substantial circumstantial support, but has yet to be 
proven. Inhibiting amyloid fibril formation with small mol- 
ecules is one approach to critically test the amyloid hypothe- 
sis in humans [55,56]. To develop inhibitors it is important 
to understand the process of amyloid fibril formation in 
some detail and in particular to identify the rate determin- 
ing step(s). In the case of amyloidogenic proteins that have 
well-defined tertiary structures (e.g. transthyretin, lysozyme 
and the immunoglobulin light chains) a significant tertiary 
structural change occurs as a result of a mutation and/or a 
partially denaturing environment that allows the protein to 
adopt an alternative conformation (typically less structured), 
which self-assembles into amyloid fibrils. These mutations 
can affect both the kinetics and thermodynamics of the 
partial denaturation process, making the formation of the 
amyloidogenic conformational intermediate occur faster and 
to a greater extent [35-38,571. 
The data presented within demonstrate that the gelsolin 
GS-173-243 fragment is a largely unstructured peptide 
that probably undergoes fibril formation via a different 
mechanism than that exhibited by folded proteins, at least 
in the initial stages [9]. The self-assembly of GS-173-243 
and the change in structure from an unordered conforma- 
tion to a P-sheet conformation associated with gelsolin 
amyloid fibril formation appears to be thermodynamically 
linked. This type of association-driven increase in structure 
is also a characteristic of the conversion of the AD peptide 
into the amyloid fibrils associated with Alzheimer’s disease 
[52,58-631. Amyloidogenic proteins therefore represent a 
structural continuum (structured to unstructured), yet both 
extremes of this continuum can form amyloid fibrils that 
are very similar in structure in aivo and in vitro, albeit by 
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Utilizing one-dimensional ‘H NMR studies of D187N GS-173-243 
gelsolin (100 PM) to evaluate the extent of defined structure. (a) The 
upfield aliphatic region and the downfield amide region of the ‘H NMR 
spectrum of D187N at pH 7.4 (10°C) is displayed. (b) The same 
regions of the ‘H NMR spectra of D187N gelsolin are displayed for the 
sample studied at pH 4.4. 
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An analysis of the binding of ANS (50 PM) to wild-type and Di 87N 
gelsolin (5 uM) as a function of pH using fluorescence emission 
spectroscopy. The data collected at pH 7.4 (50 mM phosphate; q ), 
pH 4.4 (50 mM acetate; A) and pH 2.0 (10 mM HCI, 100 mM 
NaCl; v) are shown. The same analysis for the D187N variant at 
pH 7.4 (+), pH 4.4 (0) and pH 2.0 (0) exhibits very similar results. 
mechanisms that probably differ significantly in the early 
steps, but have common late steps [50,64]. The similarity 
of the final amyloid structures and the majority of the later 
intermediates suggest that the major difference between 
the assembly of initially unordered peptides and struc- 
turally defined proteins probably occurs at the very earliest 
steps of the amyloid fibril formation mechanism(s). 
Gelsolin and A@ amyloid fibril formation are similar in that 
the Iibrils are composed of protein fragments produced 
from large parent proteins. Two proteolytic cuts in a large 
precursor protein appears to be the enabling event in 
AP fibril formation and is required, but not sufficient, for 
gelsolin amyloidosis [65-681. Gelsolin fibril formation also 
appears to require an environmental change to convert the 
fragment into amyloid fibrils. It is interesting that amyloid 
formation is not observed for the full-length gelsolin 
protein. The most likely explanation for this is the high 
kinetic barriers that are associated with the conversion of a 
large folded protein into an intermediate that can self- 
assemble into amyloid librils. The activation free energy for 
converting peptides into amyloid librils is much lower, 
based on the numerous peptides that form amyloid-like 
deposits [13,14]. Not all peptides are capable of amyloid 
formation, however. There are at least two requirements for 
peptides to form amyloid fibrils: one or more components of 
the conformational ensemble exhibited by the peptide 
must be capable of adopting an assembly competent con- 
formation; and the sequence has to be compatible with the 
higher-order assembly process associated with amyloid 
fibril formation. Ongoing studies of the D187N gelsolin 
amyloid-assembly mechanism might clarify the latter 
requirements. Because gelsolin is exclusively monomeric 
and nonamyloidogenic at pH 7.5, it is likely that pH trigger- 
ing will facilitate an excellent understanding of the early 
stages of the mechanism of amyloid fibril formation. 
Significance 
Gelsolin is an actin-binding and modifying protein that 
undergoes two endo proteolytic cuts to afford the 7I- 
residue amyloidogenic fragment. The main purpose of 
this work was to characterize the conformational prop- 
erties and amylodogenicity of this fragment. This study 
demonstrates that it is possible to overexpress and purify 
the GS-173-243 gelsolin fragment that incorporates the 
sequence found in the amyloid fib& of Finnish type 
familial amyloidosis (FAF) patients 151. Biophysical 
studies demonstrate that both the wild-type and D187N 
FAF-associated fragments are largely unstructured 
monomeric peptides that cannot spontaneously convert 
to fibrils, even after one month of incubation at pH 7.5 
(37 C). Slightly acidic conditions rapidly transform the 
wild-type and D187N amyloidogenic fragment into well 
defined fibrils, however. These results imply that proteo- 
lysis is necessary, but not sufficient, for gelsolin fibril for- 
mation. A low pH or analogous environmental change is 
also required for gelsolin GS-173-243 amyloid fibril for- 
mation in vitro on an experimental time scale. The 
inability of wild-type gelsolin to be amyloidogenic in 
humans appears to result from the resistance of the six- 
domain protein to proteolysis. In contrast, the D187N 
mutation appears to destabilize domain 2, making it sus- 
ceptible to proteolysis, which affords the 71-residue inter- 
nal amyloidogenic fragment that self-assembles into 
amyloid fibrils, possibly in an acidic organelle in vivo. 
Ongoing biophysical studies will critically evaluate the 
expected influence of the D187N mutation on gelsolin 
domain 2 stability. Hydrodynamic and microscopy 
studies on the assembly of the gelsolin D187N amyloido- 
genie fragment could provide further insight into the 
early stages of the amyloid fibril-formation mechanism. 
Materials and methods 
Cloning and expression of wild-type GS- 173-243 gelsolin 
The cDNA sequence of human plasma gelsolin, coding for amino acids 
Alai 73-Met 243, which is amyloidogenic upon the introduction of a 
point mutation at position 187, was synthesized using the polymerase 
chain reaction (PCR) using full-length plasma gelsolin cDNA template 
(GenBank accession number X0441 2) and oligodeoxyribonucleotide 
primers 1 and 2. Sense strand primer 1 (5’-ACT GGA TCC GCC 
ACC GAG GTA CCT GTG TCC-3’) with a BamHI restriction site and 
antisense primer 2 (5’.ATC AAG CTT TCA CAT CGC CTC GGG 
CTC AGT-3’) with a HindIll site were used to amplify the target cDNA 
using proof-reading Deep Vent DNA polymerase (New England 
Biolabs) according to the manufacturer’s recommendations. The ther- 
mocycling reaction was performed in a MJ Research Minicycler 
(Watertown, MA) after an initial 5 min denaturation period at 94°C 
using the following cycle profile: 94°C for 30 s, 55°C for 30 s and 
72°C for 30 s. Following a total of 25 cycles, a final extension period at 
72°C was added for 10 min. 
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The wild-type gelsolin fragment generated in the PCR reaction was 
cloned into the BamHl and Hi&Ill sites of a modified glutathione 
S-transferase (GST) fusion vector, pGAT2, and expressed in E. co/; 
BL21 (DE3) Epicurian Gold cells (Stratagene) in the form of a amino- 
terminal His-tagged, GST-fusion protein [I 51. Protein production was 
carried out at 37°C in LB media supplemented with IOO~glml ampi- 
cillin following induction with 1 mM isopropyl-P-o-thiogalactopyra- 
noside (IPTG). After 5-6 h of growth, the cells were concentrated by 
centrifugation, resuspended in phosphate buffered saline (PBS), and 
stored at -80°C until needed. 
Purification of the fusion protein was achieved by passing the total cell 
lysate through Glutathione Sepharose 4B affinity resin (Pharmacia) as 
recommended by the manufacturer, followed by elution with a solution of 
10 mM reduced glutathione (Calbiochem) dissolved in 50 mM Tris-HCl, 
pH 8.0. Direct addition of bovine thrombin (Sigma T4648) to the eluant 
from the glutathione column at a ratio of 0.2 units of enzyme per milligram 
of fusion protein liberated the gelsolin peptide that had two additional 
amino-terminal residues, glycine (-2) and serine (-1) from the His- 
tagged, GST-fusion protein. Following 4 h of proteolysis at room temper- 
ature with gentle mixing on a lab rotator, cleaved GST was removed from 
the target peptide by passing the reaction mixture through Ni-NTA- 
Agarose resin (Qiagen). The eluant from the Ni-NTA column, which con- 
tained the gelsolin fragment, was concentrated by ultrafiltration with a 
YM3 membrane (Amicon) and then purified to homogeneity by gel per- 
meation chromatography on a HiLoad 26/60 Superdex 30 column (Phar- 
macia). An SDS-PAGE gel modified for peptides and small proteins was 
used to visualize the gelsolin fragment to confirm its presence and purity 
[691. The identity of the purified gelsolin fragment was confirmed by 
cDNA sequencing and by electrospray mass spectrometty. 
D187N and D187Y amyloidogenic mutants 
The two point mutations that are found in the gelsolin amyloid deposits 
of FAF patients both occur at position 187, and involve replacing an 
aspartate residue with either a tyrosine or asparagine reside. These two 
mutations were synthesized using the GuickChange Site-Directed 
Mutagenesis protocol from Stratagene with wild-type gelsolin 
173-243 fragment as the template. The Dl87Y mutant (nucleotide 
base change from G to T  at position 654) was generated using the 
oligodeoxyribonucleotide 5’-GCT TCA ACA ATG GCT ACT GCT TCA 
TCC TGG-3’ and its inverse complement, whereas the oligodeoxyri- 
bonucleotide 5’-GCT TCA ACA ATG GCA ACT GCT TCA TCC TGG- 
3’ and its inverse complement were used to introduce the D187N 
mutation (nucleotide base change from G to A). Fourteen cycles each 
for 30 s at 95°C for denaturation, 1 min at 55% for annealing and 
12 min at 68°C for primer extension were executed to introduce the 
mutations at position 187. The presence of both mutations was con- 
firmed by cDNA sequencing. Production and purification of the amy- 
loidogenic gelsolin fragments was carried out as detailed above for the 
wild-type gelsolin peptide. The D187N peptide was used for the major- 
ity of our studies, although future work will also evaluate the GS 
173-243 gelsolin Dl87Y variant using the studies described within. 
Preliminary results (pH independent fluorescence anisotropy values 
and amyloid formation below pH 6.0 only) suggest that Dl87Y mutant 
behaves similar to the Dl87N mutant studied here. 
Gelsolin fibril formation assays 
Sample preparation. Solutions of the purified gelsolin fragments 
(173-243) at both 2.5 and 25 uM were prepared from a stock solution 
of gelsolin (0.1 mM in PBS pH 7.4) by dilution into either 50 mM phos- 
phate (pH 7.4 to 6.0) or 50 mM acetate (pH 6.0-4.0) buffer solutions 
containing 100 mM NaCI. The dilution buffers differed from one 
another by 0.5 pH units, allowing the amyloidogenicity to be evaluated 
over the pH range from 4-7.5. These samples were incubated without 
any agitation at 37°C or 4°C for 3-5 days before the light scattering 
and Congo red binding assays were performed. All samples were 
assayed in triplicate. Some samples from the above assays were 
further incubated at 37°C and evaluated after 2 months of stagnant 
incubation to discern if fibril formation was occuring, albeit slowly. Grid 
searches by electron microscopy were conducted for representative 
samples to further scrutinize amyloid fibril formation. 
Light scattering assay. The stationary samples were vortexed for a few 
seconds to distribute the fibrils evenly. The sample (400 pl) was trans- 
ferred to a quartz cuvette and the optical density at 330 nm was 
recorded on a Hewlett Packard 8543 UVlVis spectrophotometer. The 
three values obtained at each pH were averaged and plotted using 
Kaleidograph. 
Congo Red binding assay. A procedure developed by Klunk et a/. [I 61 
was used to ensure that the light scattering detected came from 
amyloid as opposed to amorphous aggregates. Vortexed samples of 
the gelsolin fragments (100 ul) were added to 550 ul of a 10 pM solu- 
tion of freshly prepared Congo red that was purified by recrystallization. 
The solutions were incubated at room temperature for 1 h before the 
absorbance spectra were recorded. The amount of Congo red bound 
to the fibrils was determined by the following relationship: 
moles of CR bound/l of amyloid suspension = 
(A,,,/25295) - (A,,,/46306) 
The three values obtained at each pH were averaged and plotted 
using Kaleidograph. 
FT-IR spectroscopy of the fibrils 
Fibrils were obtained by incubating 25 uM solutions of the wild-type or 
Dl87N GS-173-243 gelsolin fragments at pH 4.0 (50 mM acetate, 
100 mM NaCl in 100% D,O) at 37°C for 2 weeks. The pH was uncor- 
rected for isotope effects. Soluble protein not converted to fibrils was 
removed by centrifuging the suspensions at 14,000 rpm using a table- 
top microfuge and discarding the supernatant. The fibrils were washed 
a second time by resuspending the fibrils in buffer, centrifuging and 
discarding the supernatant. The fibrils were then applied to CaF, 
plates and dried under vacuum in a dessicator. Infrared spectra from 
1000 cm-’ to 4000 cm-’ were recorded on a Nicolet Magna FT-IR 
spectrometer equipped with an MCT detector at room temperature. 
The resolution was 4 cm-l and 512 scans were averaged for each 
sample. The spectra were then subtracted from that of the blank, 
which was acquired using a similar procedure using a CaF, plate 
without any sample applied. The data was smoothed and the band 
locations determined with the use of the second derivative spectra. 
Evaluation of the gelsolin oxidation state by reverse-phase 
HPLC analysis 
Three samples each of wild-type and Dl87N gelsolin (100 pl of a 
50 PM solution), were prepared for this analysis. The first set of gel- 
solin GS-(173-243) samples (wild-type and Dl87N) was derived 
from an aliquot of freshly purified gelsolin polypeptide obtained imme- 
diately after the gel filtration chromatography, as described in the 
purification protocol. The second set of samples was prepared by 
treating wild-type and Dl87N gelsolin 173-243 with 30 mM DTT at 
room temperature for 30 min to ensure complete reduction of the 
disulfide bond. The third set of gelsolin samples (wild-type and 
Dl87N 173-243) was treated with an oxidative reshuffling buffer 
(3 mM cystine, 0.3 mM cysteine, 1 mM EDTA at pH 9.0) to ensure 
complete oxidation [70,711. The HPLC chromatograms for a C,s 
reverse phase (Vydac Cl 8 analytical) analysis for all of these samples 
were obtained using a 5 to 80% linear gradient of solvent B over 
45 min (solvent A: 950/o water, 5% acetonitrile, 0.1 O/o TFA and solvent 
B: 95% acetonitrile, 5% water, 0.1% TFA). The reduced peptides 
eluted from the column with a retention time of 25 min (46% B) 
whereas the oxidized disulfide-linked peptides eluted with a retention 
time of 22 min (41% B). 
Electron microscopy 
A fibril suspension (5 ul) derived from the samples used for the fibril- 
forming assays were applied to glow-discharged, carbon-coated 
copper grids (mesh size 200A) for 2 min and blotted with Whatman 
302 Chemistry & Biology 1999, Vol 6 No 5 
filter paper to remove excess solution. The grids were then stained with 
a 1% uranyl acetate solution for 2 min and excess stain was blotted 
away with filter paper. The grids were air dried and examined with a 
Philips CM1 00 transmission electron microscope at 80 KeV. 
Fluoresence anisotropy measurements 
Single point polarization data were obtained for both wild-type and 
D187N GS-173-243 fragments of gelsolin as a function of pH (7.4 to 
2.0). The initial sample was a 1OyM solution of gelsolin in PBS at 
pH 7.4. The pH of the sample was lowered throughout the course of 
the experiment by titrating the sample with aliquots of a dilute acetic 
acid solution until the required pH was obtained. Six data points were 
acquired for the D187N polypeptide and seven data points were 
acquired for the wild-type gelsolin fragment. In order to acquire data at 
pH 2.0, the sample was further titrated with dilute HCI. The experi- 
ments were performed at room temperature using a SLM-AMINCO 
8100 Series 2 spectrofluorometer in a T-optic configuration to obtain 
simultaneous measurements of the vertical (I) and horizontal (11) emis- 
sion components of the polarized light. The exitation wavelength was 
280 nm and the emission wavelength was 350 nm. Twenty five scans 
were averaged at each pH value with an integration time of 3 s, which 
was sufficient to obtain a standard deviation of 0.001 anisotropy units 
or less. The averaged data was plotted using Kaleidograph. 
The fluorescence emission anistropy is defined as (A) = I,,-11/1,, + 21, 
[72]; where I,, is the emission intensity parallel to the plane of excitation 
and Ii is the emission intensity perpendicular to the plane of excitation. 
NMR spectroscopy 
Wild-type and D187N gelsolin (GS-173-243) samples (0.1 mM) in 
PBS buffer at pH 7.4. (90% H,O, 10% D,O) were prepared. The IH one- 
dimensional NMR spectrum was recorded with a spectral width of 
8064 Hz at pH 7.4 and 4.4. The pH of the PBS buffered sample was 
lowered by adding deuterated acetic acid until the desired pH of 4.4 was 
reached to record the data at lower pH. All spectra were acquired on a 
Bruker AMX500 spectrometer operating at 499.87 MHz at a probe tem- 
perature of 10°C. Water suppression was achieved employing the water 
gate sequence and 512 scans were averaged for each sample. An expo- 
nential window function was applied to the interferograms before fourier 
transformation. The data was processed using NMRPipe and NMRDraw 
(NIH software) on a Silicon Graphics Indigo 2 workstation, The spectra 
were referenced to TSP (0.0 ppm) which was added to the sample. 
H-D exchange NMR experiments 
Protein samples were dialysed into water and lyophilized. The 
GS-173-243 gelsolin fragment (0.4 mgs) was added to 400 pl of PBS 
buffer at pH 7.4 (100% D,O, pH uncorrected for D isotope effects), 
yielding a final protein concentration of 0.1 mM. The one-dimensional 1H 
spectra of these samples were acquired within 5 min of dissolution. For 
each sample 32 scans were collected, with a spectral width of 8064 Hz. 
The data were processed as described above. 
8-Anilino- 1 -naphthalenesulfonic acid CANS) binding 
A stock solution of 8-anilino-1-naphthalene sulfonic acid (ANS; Sigma 
A51 44) prepared in deionized H,O was added to both the wild-type and 
D187N (GS-173-243) gelsolin peptides producing samples with a 
final ANS concentration of 50 pM and a peptide concentration of 5 PM. 
The ANS concentration was determined by UV absorbance measure- 
ments at 372 nm using a molar extinction coefficient of 7800 M-1 cm-r. 
Wild-type and D187N (GS-173-243) gelsolin peptides at pH 7.4 and 
pH 4.4 were prepared by dialysis against 50 mM sodium phosphate, 
pH 7.4 and 50 mM sodium acetate, pH 4.4, respectively. Preparations 
of gelsolin samples at pH 2.0 were made from lyophilized gelsolin which 
was initially resuspended in a solution of 10 mM HCI and 100 mM NaCl 
and then adjusted to the desired pH. The final volume of each sample 
analyzed was 1 .O ml. Fluorescence emission spectra were recorded on 
an Aviv Model ATF105 automated titrating differential/ratio spectrofluo- 
rometer at 25°C using an excitation wavelength of 375 nm with both the 
excitation and emission slit widths set to 2 mm. 
Far-W CD studies 
All CD studies were performed on an AVIV Model 202SF Stopped 
Flow Circular Dichroism Spectrometer (Lakewood, NJ) equipped with a 
Peltier temperature-controlled cell holder. The CD spectra represented 
in Figure 7 are averages of three consecutive steady state scans which 
were corrected by subtracting a buffer blank (time constant of 
100 msec, sampling at 0.2 nm intervals). Far-UV CD spectra were col- 
lected on 25 pM solutions of wild-type and D187N GS-173-243 pep- 
tides in 50 mM sodium phosphate (pH 7.4) or 50 mM sodium acetate 
buffer (pH 4.0), 100 mM NaCl at 4°C in a 0.1 cm pathlength quartz cell 
and are reported in units of mean residue ellipticity (MRE). 
Supplementary material 
Supplementary material demonstrating that the wild-type and D187N 
gelsolin fragments are monomeric (25 PM) at pH 7.4 (and therefore 
suitable for amyloidogenicity and biophysical studies) is available with 
the online version of this paper. 
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